Anti-GPC6A/ GPRC6A/ GPCR monoclonal antibody
Anti-GPC6A/ GPRC6A/ GPCR antibody for FACS & in-vivo assay
Go to GPRC6A/GPRC6A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T72032-Ab-1/ GM-Tg-hg-T72032-Ab-2 | Anti-Human GPRC6A monoclonal antibody | Human |
GM-Tg-rg-T72032-Ab-1/ GM-Tg-rg-T72032-Ab-2 | Anti-Rat GPRC6A monoclonal antibody | Rat |
GM-Tg-mg-T72032-Ab-1/ GM-Tg-mg-T72032-Ab-2 | Anti-Mouse GPRC6A monoclonal antibody | Mouse |
GM-Tg-cynog-T72032-Ab-1/ GM-Tg-cynog-T72032-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GPRC6A monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T72032-Ab-1/ GM-Tg-felg-T72032-Ab-2 | Anti-Feline GPRC6A monoclonal antibody | Feline |
GM-Tg-cang-T72032-Ab-1/ GM-Tg-cang-T72032-Ab-2 | Anti-Canine GPRC6A monoclonal antibody | Canine |
GM-Tg-bovg-T72032-Ab-1/ GM-Tg-bovg-T72032-Ab-2 | Anti-Bovine GPRC6A monoclonal antibody | Bovine |
GM-Tg-equg-T72032-Ab-1/ GM-Tg-equg-T72032-Ab-2 | Anti-Equine GPRC6A monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T72032-Ab-1/ GM-Tg-hg-T72032-Ab-2; GM-Tg-rg-T72032-Ab-1/ GM-Tg-rg-T72032-Ab-2; GM-Tg-mg-T72032-Ab-1/ GM-Tg-mg-T72032-Ab-2; GM-Tg-cynog-T72032-Ab-1/ GM-Tg-cynog-T72032-Ab-2; GM-Tg-felg-T72032-Ab-1/ GM-Tg-felg-T72032-Ab-2; GM-Tg-cang-T72032-Ab-1/ GM-Tg-cang-T72032-Ab-2; GM-Tg-bovg-T72032-Ab-1/ GM-Tg-bovg-T72032-Ab-2; GM-Tg-equg-T72032-Ab-1/ GM-Tg-equg-T72032-Ab-2 |
Products Name | Anti-GPRC6A monoclonal antibody |
Format | mab |
Target Name | GPRC6A |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-GPRC6A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species GPC6A/ GPRC6A/ GPCR VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | vGMLV000022 | human GPRC6A Lentivirus particle |
ORF Viral Vector | pGMLV000022 | human GPRC6A Lentivirus plasmid |
ORF Viral Vector | pGMLPm004488 | mouse Gprc6a Lentivirus plasmid |
ORF Viral Vector | vGMLPm004488 | mouse Gprc6a Lentivirus particle |
Target information
Target ID | GM-T72032 |
Target Name | GPRC6A |
Gene ID | 222545,210198,294394,715520,484095,101092611,783669,100067090 |
Gene Symbol and Synonyms | bA86F4.3,GPCR,GPRC6A |
Uniprot Accession | Q5T6X5,Q70VB1,E1BPQ3 |
Uniprot Entry Name | GPC6A_HUMAN,GPC6A_RAT,GPC6A_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | Cancer |
Gene Ensembl | ENSG00000173612 |
Target Classification | Tumor-associated antigen (TAA) |
The target: GPRC6A, gene name: GPRC6A, also named as GPCR, bA86F4.3. 0.
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.